Are Cell and Gene Therapy Innovations Ready for Widespread Use?

The challenges healthcare executives and administrators face are constantly changing. Host Kevin Stevenson talks with the heroes behind the heroes that are enabling hospitals, urgent care centers and telemedicine operators to spend their time tending to patients, while they handle the logistics.

 

Treatment of diseases like cancer and HIV is hitting a new frontier with cell-based therapy. This new therapy invigorates the medical world, but it’s not widely accessible yet. Discussing the breakthroughs in these treatments, I Don’t Care host Kevin Stevenson spoke with immunologist Dr. Chris Xu, CEO of ThermoGenesis, a medical device company that’s a pioneer in the field.

“Cell-based therapy came about 13 years ago, and we’ve been fostering the field around cord blood, with 90% of FDA approved cord blood stored in a nitrogen system we developed,” Dr. Xu explained.

That was the company’s beginning, but it has aspirations to do much more. That requires a shift in treatment perspective. “We’ve long used drugs to treat illnesses, but cancer is much more complex. The newly approved therapy takes a patient’s T-cells, which are part of the immune system. It reprograms them to recognize cancer and fight it. It’s the future of medicine,” Dr. Xu said.

“Using someone’s T-cells turns their body into the best defense mechanism against disease.” – Dr. Chris Xu

Thus far, Dr. Xu reported that patients with leukemia and lymphomas have a 93% response rate. He also noted that cancer treatment is just the beginning. Over 1200 trials targeting every type of cancer are ongoing.

HIV is another disease where cell gene therapy has promise. “We discovered that a small percentage of the population doesn’t carry the receptor for HIV, which is necessary for the virus to enter a cell. We can modify cells not to have it, making the patient HIV resistant.”

While the promise of new treatments is here, Dr. Xu noted there are two big impediments. One is cost, with treatments costing as much as $500,000. The other is that patients may no longer have T-cells due to radiation, chemo, or other issues. That’s why he recommends storing cord blood for future use.

Listen to Previous Episodes of I Don’t Care!

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

payments
Revolutionizing Payments: Discover the Power of PayPal for Your Business
June 24, 2025

Unlock seamless transactions and elevate your business operations with PayPal’s innovative payment solutions. Harness the platform trusted by millions to drive financial efficiency, streamline processes, and enhance security. What You’ll Learn Why PayPal is the Go-to Solution for Small Businesses Leveraging PayPal and Venmo for Multi-Channel Capability Enabling Seamless Integration with PayPal’s Tools Essential…

Read More
Customer Experience
Why Customer Experience Is Your Most Powerful Growth Lever—and How to Use It to Drive Referrals, Retention, and Revenue
June 24, 2025

In an era where marketing is shifting faster than most can keep up with, staying informed is a challenge for even the most seasoned revenue leaders. From AI upending traditional search to MarTech tools bloating underused tech stacks, the ground beneath B2B marketers is shifting. According to McKinsey, companies leading in customer experience are…

Read More
last mile optimization
Supply Chain Leaders Must Abandon Outdated Routing and Embrace Last Mile Optimization Through Modeling and AI
June 24, 2025

As geopolitical tensions disrupt global shipping and tariffs create fresh uncertainty in international trade, companies are being forced to reexamine their most vulnerable supply chain segment—the last mile . While upstream operations get the spotlight during crises, the final leg of delivery remains a persistent blind spot. That oversight has consequences: empty trucks, fragmented delivery…

Read More
patient financial journey
RevSpring Uses Data, Automation and Empathy to Improve the Patient Financial Journey – Better Outcomes for Patients, Less Burden for Providers
June 24, 2025

Healthcare providers are under increasing pressure to meet consumer expectations without adding an administrative burden. According to a survey conducted by The Harris Poll in June 2024, 18% of the 2,092 American adults who were surveyed had received an unexpected medical bill of $1,000 or more in the past year, and 50% said they would…

Read More